2015
An Outbreak of Severe Group A Streptococcus Infections Associated with Podiatric Application of a Biologic Dermal Substitute
Ibrahim LA, Sellick JA, Watson EL, McCabe LM, Schoenhals KA, Martinello RA, Lesse AJ. An Outbreak of Severe Group A Streptococcus Infections Associated with Podiatric Application of a Biologic Dermal Substitute. Infection Control And Hospital Epidemiology 2015, 37: 306-312. PMID: 26673775, DOI: 10.1017/ice.2015.306.Peer-Reviewed Original ResearchConceptsSevere group A Streptococcus (GAS) infectionsGroup A Streptococcus InfectionStreptococcus infectionSubstitute useDermal substituteVeterans Affairs Medical CenterEmm type 28Inter-patient transmissionSETTING/PATIENTSRetrospective cohort studyMicrobiology laboratory dataCase-cohort studyInfection control techniquesNumber of patientsPrior strokeUninfected patientsCohort studyPodiatry clinicFoot woundsPatient cohortRisk factorsCase definitionClinic staffEmm typingMedical Center
2006
Life-Threatening Sepsis Caused by Burkholderia cepacia From Contaminated Intravenous Flush Solutions Prepared by a Compounding Pharmacy in Another State
Held MR, Begier EM, Beardsley DS, Browne FA, Martinello RA, Baltimore RS, McDonald LC, Jensen B, Hadler JL, Dembry LM. Life-Threatening Sepsis Caused by Burkholderia cepacia From Contaminated Intravenous Flush Solutions Prepared by a Compounding Pharmacy in Another State. Pediatrics 2006, 118: e212-e215. PMID: 16785290, DOI: 10.1542/peds.2005-2617.Peer-Reviewed Original ResearchConceptsBlood culturesOutside health care facilityBurkholderia cepacia sepsisLife-threatening casesLife-threatening sepsisPatient's blood culturesHealth care facilitiesInfusate contaminationPulsed-field gel electrophoresisFlush solutionCare facilitiesSafe deliverySepsisCompounding pharmaciesBacterial isolatesBurkholderia cepaciaMedicationsPatientsInfusate